PT302 – Dr. Adele Lafrance – Vital Psychedelic Conversations

How Can We Apply Harm Reduction to HPPD?

Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London...

Green Market Report – Are Psychedelics Leaving Minorities Behind?

MINDCURE Provides Update on Strategic Review

Nova Mentis Announces Closing of Non-Brokered Financing

Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and...

PT301 – Kabir Ali – Addiction, Ketamine, and the Overlooked Gift...

Numinus Expands Natural Psychedelic Research with New Biosecurity License

Load more